Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVERS.L Regulatory News (VERS)

  • There is currently no data for VERS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

20 Nov 2019 16:33

RNS Number : 1145U
Verseon Corporation
20 November 2019
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (596/2014/EU) ("MAR").

November 20, 2019

 

Verseon Corporation

 

("Verseon" or the "Company")

 

Transaction in Own Shares, Related Party Transaction, and Update on Tender Offer

 

FREMONT, Calif.-Further to its announcements earlier today, Verseon announces that, through its wholly owned subsidiary VSH1, the Company has purchased 35,087,966 Common Shares in the Company, formerly owned by Woodford Investment Management Limited, from Link Fund Solutions Ltd ("Link") at 1.56 pence per share (the "Purchase"). The Company intends to use the share price from the Purchase as the price per share for its planned tender offer to other shareholders. Further details of the tender offer will be released as soon as practically possible.

Total Voting Rights

Following the Purchase, the issued share capital of the Company will consist of 159,737,905 Common Shares and the Company will hold 42,917 shares in treasury. Therefore, the total number of Common Shares in the Company with voting rights will be 159,694,988. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

Related Party Transaction

Due to Link's substantial shareholding in the Company, Verseon's share purchase from Link is classified as a related party transaction under the AIM Rules for Companies. The Directors of the Company, having consulted with the Company's Nominated Adviser, Arden Partners plc, consider that the terms of the transaction are fair and reasonable insofar as the shareholders are concerned.

- Ends -

For further information, please contact:

Verseon Corporation

www.verseon.com

Sebastian Wykeham / Tina Schlafly

+1 (510) 225 9000

 

 

Arden Partners (NOMAD and Broker)

 

Ruari McGirr / Ciaran Walsh / Dan Gee-Summons (Corporate Finance)

 +44 (0) 20 7614 5900

 

For trade and pharma media enquiries, please contact

Vane Percy & Roberts

 

Simon Vane Percy

+44 (0) 1737 821 890

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSLLFFRLALIFIA
Date   Source Headline
27th Oct 20168:41 amRNSAdditional Listing & Total Voting Rights
21st Sep 20167:00 amRNSDirector/PDMR Shareholding
12th Sep 20167:00 amRNSAdditional Listing & Total Voting Rights
8th Sep 20167:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
5th Sep 20167:00 amRNSInterim Results
9th Aug 201611:40 amRNSAdditional Listing & Total Voting Rights
22nd Jun 20167:00 amRNSAdditional Listing & Total Voting Rights
6th Jun 20167:00 amRNSVerseon to Present Latest Anticoagulant Results
27th Apr 20167:00 amRNSAdditional Listing & Total Voting Rights
21st Apr 20167:00 amRNSResult of AGM
7th Apr 20167:00 amRNSNotice of AGM
6th Apr 20167:00 amRNSTR-1: Notification of Major Interest in Shares
4th Apr 20167:00 amRNSVerseon to present additional results at BioEurope
21st Mar 20167:00 amRNSHoldings in Company
17th Mar 20167:00 amRNSAdditional Listing & Total Voting Rights
7th Mar 20167:00 amRNSFinal Results
1st Mar 20167:00 amRNSAdditional Listing & Total Voting Rights
29th Feb 20167:00 amRNSVerseon presents low bleeding risk anticoagulants
10th Feb 20167:00 amRNSVerseon to present new preclinical results at ICHB
4th Feb 20167:00 amRNSAdditional Listing & Total Voting Rights
12th Jan 20167:00 amRNSVerseon to Present Data
29th Dec 201510:15 amRNSAdditional Listing & Total Voting Rights
29th Oct 20157:00 amRNSAdditional Listing & Total Voting Rights
25th Sep 20157:00 amRNSAdditional Listing & Total Voting Rights
17th Sep 20157:00 amRNSTR-1: Notification of Major Interest in Shares
15th Sep 20157:00 amRNSTR-1: Notification of Major Interest in Shares
7th Sep 20157:00 amRNSInterim Results
28th Aug 20159:34 amRNSDepository Interest Programme
20th Aug 20158:55 amRNSVerseon Acquires R&D Facility
19th Aug 20159:09 amRNSAdditional Listing & Total Voting Rights
22nd Jul 20158:39 amRNSAdditional Listing & Total Voting Rights
29th Jun 20158:58 amRNSAnnual Report Announcement
25th Jun 20159:57 amRNSHolding(s) in Company
17th Jun 20157:00 amRNSAdditional Listing & Total Voting Rights
7th May 20158:12 amRNSAIM Admission - First day of dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.